HUP9800115A1 - Rifaximin alkalmazása kriptosporidiózis következtében fellépő hasmenés kezelésére használható gyógyszerkészítmények előállítására - Google Patents
Rifaximin alkalmazása kriptosporidiózis következtében fellépő hasmenés kezelésére használható gyógyszerkészítmények előállításáraInfo
- Publication number
- HUP9800115A1 HUP9800115A1 HU9800115A HUP9800115A HUP9800115A1 HU P9800115 A1 HUP9800115 A1 HU P9800115A1 HU 9800115 A HU9800115 A HU 9800115A HU P9800115 A HUP9800115 A HU P9800115A HU P9800115 A1 HUP9800115 A1 HU P9800115A1
- Authority
- HU
- Hungary
- Prior art keywords
- rifaximin
- cryptosporediosis
- preparation
- pharmaceutical compositions
- immune system
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 2
- NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical compound OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 title abstract 2
- 229960003040 rifaximin Drugs 0.000 title abstract 2
- 206010012735 Diarrhoea Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000030507 AIDS Diseases 0.000 abstract 2
- 210000000987 immune system Anatomy 0.000 abstract 2
- 208000024891 symptom Diseases 0.000 abstract 2
- 208000008953 Cryptosporidiosis Diseases 0.000 abstract 1
- 206010011502 Cryptosporidiosis infection Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 230000000741 diarrhetic effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A találmány tárgya rifaximin alkalmazása kriptőspőridiózisős(Cryptőspőridiűm parvűm fertőzés) esetek hasmenéses tüneteinekkezelésére - imműndepresszió (az imműnrendszer csökkent működése)súlyős főrmáiban szenvedő betegeknél, példáűl AIDS-ben (szerzettimműnhiányős tünetegyüttesben), vagy rősszindűlatú daganatképződésbenszenvedő, vagy szervátültetésen átesett, vagy kemőterápiásan, illetveimműnszűppresszív (az imműnrendszer működését gátló) hatóanyagőkkalkezelt betegeknél - szőlgáló gyógyszerkészítmények előállítására. ŕ
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97BO000064A IT1290679B1 (it) | 1997-02-14 | 1997-02-14 | Uso della rifaximina e delle composizioni farmaceutiche che la contengono nel trattamento della diarrea da criptosporidiosi. |
Publications (4)
Publication Number | Publication Date |
---|---|
HU9800115D0 HU9800115D0 (en) | 1998-03-30 |
HUP9800115A1 true HUP9800115A1 (hu) | 1999-06-28 |
HUP9800115A3 HUP9800115A3 (en) | 2000-04-28 |
HU224592B1 HU224592B1 (hu) | 2005-11-28 |
Family
ID=11341939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9800115A HU224592B1 (hu) | 1997-02-14 | 1998-01-22 | Rifaximin alkalmazása kriptosporidiózis következtében fellépő hasmenés kezelésére használható gyógyszerkészítmény előállítására |
Country Status (12)
Country | Link |
---|---|
US (1) | US5886002A (hu) |
EP (1) | EP0858804B1 (hu) |
JP (1) | JP4848083B2 (hu) |
KR (1) | KR100436243B1 (hu) |
CN (1) | CN1115146C (hu) |
AT (1) | ATE218342T1 (hu) |
DE (1) | DE69805672T2 (hu) |
DK (1) | DK0858804T3 (hu) |
ES (1) | ES2178048T3 (hu) |
HU (1) | HU224592B1 (hu) |
IT (1) | IT1290679B1 (hu) |
PT (1) | PT858804E (hu) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
JP2006525329A (ja) * | 2003-04-30 | 2006-11-09 | ジ インスチチュート フォー ファーマシューティカル ディスカバリー、エルエルシー | 置換カルボン酸類 |
US20060210483A1 (en) * | 2005-03-02 | 2006-09-21 | Kodsi Robert E | Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections |
US8003118B2 (en) * | 2005-03-02 | 2011-08-23 | Kodsi Robert E | Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis |
US20060210492A1 (en) * | 2005-03-02 | 2006-09-21 | Kodsi Robert E | Use of rifaximin for treatment and prevention of periodontal conditions |
ES2522895T3 (es) | 2005-03-03 | 2014-11-19 | Alfa Wassermann S.P.A. | Nuevas formas polimorfas de rifaximina, procedimientos para su producción y uso de las mismas en preparados medicinales |
ITBO20050123A1 (it) * | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
WO2008016708A2 (en) * | 2006-08-02 | 2008-02-07 | Salix Pharmaceuticals, Inc. | Methods for treatment of radiation enteritis |
US20080161337A1 (en) * | 2007-01-03 | 2008-07-03 | Leonard Weinstock | Use of Rifaximin for the Treatment of Chronic Prostatitis |
US20080159987A1 (en) * | 2007-01-03 | 2008-07-03 | Leonard Weinstock | Use of Rifaximin for the Treatment of Restless Legs Syndrome |
ES2496190T3 (es) * | 2008-09-26 | 2014-09-18 | Aska Pharmaceutical Co., Ltd. | Agente profiláctico y/o terapéutico para trastornos gastrointestinales funcionales |
US20110035232A1 (en) | 2008-10-02 | 2011-02-10 | Salix Pharmaceuticals, Ltd. | Methods of treating hepatic encephalopathy |
BRPI0920465A2 (pt) | 2008-10-02 | 2018-03-20 | Salix Pharmaceuticals, Inc. | metodo de tratamento de encefalopatia hepática |
EP2503989A2 (en) | 2009-11-23 | 2012-10-03 | Cipla Limited | Topical foam composition |
IT1398550B1 (it) | 2010-03-05 | 2013-03-01 | Alfa Wassermann Spa | Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo |
JP6092629B2 (ja) * | 2010-03-10 | 2017-03-08 | ルピン・リミテッドLupin Limited | リファキシミン使用準備済懸濁液 |
RU2013113752A (ru) | 2010-09-13 | 2014-10-20 | Сипла Лимитед | Фармацевтическая композиция |
WO2012076832A1 (en) | 2010-12-09 | 2012-06-14 | Cipla Limited | Suppositories comprising rifaximin |
ITBO20110461A1 (it) | 2011-07-29 | 2013-01-30 | Alfa Wassermann Spa | Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali. |
EP2927235B1 (en) | 2014-03-31 | 2017-02-08 | Euticals S.P.A. | Polymorphic mixture of rifaximin and its use for the preparation of solid formulations |
WO2015173697A1 (en) | 2014-05-12 | 2015-11-19 | Alfa Wassermann S.P.A. | New solvated crystal form of rifaximin, production, compositions and uses thereof |
MX2016016458A (es) * | 2014-06-30 | 2017-07-13 | Salix Pharmaceuticals Inc | Métodos para repetir tratamiento de síndrome del intestino irritable (ibs). |
WO2016138118A1 (en) * | 2015-02-26 | 2016-09-01 | Jaguar Animal Health, Inc. | Use of croton- or calophyllum-derived proanthocyanidin polymers or botanical extracts in combination with rifaximin for the treatment of diarrhea in non-human animals |
WO2016200614A2 (en) * | 2015-06-10 | 2016-12-15 | Synlogic, Inc. | Bacteria engineered to treat diseases associated with hyperammonemia |
CN110087688B (zh) | 2016-10-14 | 2023-05-05 | 希普拉有限公司 | 包含利福昔明的药物组合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1264494B1 (it) * | 1993-03-23 | 1996-09-24 | Alfa Wassermann Spa | Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter |
-
1997
- 1997-02-14 IT IT97BO000064A patent/IT1290679B1/it active IP Right Grant
-
1998
- 1998-01-22 AT AT98101081T patent/ATE218342T1/de active
- 1998-01-22 DK DK98101081T patent/DK0858804T3/da active
- 1998-01-22 PT PT98101081T patent/PT858804E/pt unknown
- 1998-01-22 ES ES98101081T patent/ES2178048T3/es not_active Expired - Lifetime
- 1998-01-22 HU HU9800115A patent/HU224592B1/hu active IP Right Grant
- 1998-01-22 DE DE69805672T patent/DE69805672T2/de not_active Expired - Lifetime
- 1998-01-22 EP EP98101081A patent/EP0858804B1/en not_active Expired - Lifetime
- 1998-01-26 US US09/013,655 patent/US5886002A/en not_active Expired - Lifetime
- 1998-02-12 JP JP02981398A patent/JP4848083B2/ja not_active Expired - Lifetime
- 1998-02-13 KR KR10-1998-0004389A patent/KR100436243B1/ko not_active IP Right Cessation
- 1998-02-13 CN CN98106920A patent/CN1115146C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0858804B1 (en) | 2002-06-05 |
KR19980071348A (ko) | 1998-10-26 |
ATE218342T1 (de) | 2002-06-15 |
DE69805672T2 (de) | 2003-01-23 |
JP4848083B2 (ja) | 2011-12-28 |
US5886002A (en) | 1999-03-23 |
CN1115146C (zh) | 2003-07-23 |
EP0858804A1 (en) | 1998-08-19 |
IT1290679B1 (it) | 1998-12-10 |
KR100436243B1 (ko) | 2004-08-25 |
DK0858804T3 (da) | 2002-07-08 |
DE69805672D1 (de) | 2002-07-11 |
HU224592B1 (hu) | 2005-11-28 |
ITBO970064A1 (it) | 1998-08-14 |
JPH10226645A (ja) | 1998-08-25 |
PT858804E (pt) | 2002-10-31 |
HUP9800115A3 (en) | 2000-04-28 |
ES2178048T3 (es) | 2002-12-16 |
ITBO970064A0 (it) | 1997-02-14 |
HU9800115D0 (en) | 1998-03-30 |
CN1214244A (zh) | 1999-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9800115A1 (hu) | Rifaximin alkalmazása kriptosporidiózis következtében fellépő hasmenés kezelésére használható gyógyszerkészítmények előállítására | |
IL149995A0 (en) | Depsipeptides and pharmaceutical compositions containing the same | |
DE69713151D1 (de) | Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung | |
NO20100777L (no) | Kinazolinoner, slike forbindelser for anvendelse som medikament, farmasoytiske preparater inneholdende slike samt anvendelse av slike for fremstilling av medikament for behandling av sykdom | |
EA200601132A1 (ru) | Предупреждение и лечение амилоидогенного заболевания | |
ATE297208T1 (de) | Tablette mit verlängerter wirkstoffabgabe zur behandlung der parkinsonkrankheit | |
BG101118A (en) | Therapeutical compounds | |
FR2757522B1 (fr) | Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent | |
MY133393A (en) | Phenyl xanthine derivatives | |
DE69426334D1 (de) | Parenterales Busulfan zur Behandlung von malignen Krankheiten | |
DE69435091D1 (de) | Nigella sativa als medizinische behandlung | |
PL364359A1 (en) | Treatment or prophylaxis of insulin-producing cell graft rejection | |
ATE308331T1 (de) | Kombinationspräparat enthaltend monozyten- abgeleitete zellen zur behandlung von neoplastischen oder infektiösen erkrankungen | |
BR9709838A (pt) | Regime de administração que fornece um perfil de plasma no sangue de um inibidor de h+,k+-atpase composição farmacêutica oral uso da mesma e de inibidor h+,k+-atpase e processos para melhorar a inibição de secreção de ácido gástrico e o efeito terapêutico no tratamento de perturbações gastrintestinais e para receber um perfil estendido de plasma de um inibidor de h+,k+-atpase | |
HK1068606A1 (en) | Novel aminobenzoephenones | |
AU1794601A (en) | Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs | |
HUP0003904A1 (hu) | Ciklosporinok és tacrolimus által okozott nephrotoxicitas megelőzésére alkalmas eljárás | |
IL121272A (en) | Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia | |
HUP9901353A2 (hu) | ACE-inhibitorok alkalmazása diszpepsziás tünetek kezelésére alkalmas gyógyszerkészítmény előállítására | |
MXPA00010254A (es) | Tratamiento de disfuncion sexual en ciertos grupos de pacientes. | |
Fowler | AIDS survival progress | |
TR200401810T4 (tr) | Kısırlık tedavisinde fsh'ın kullanılması | |
HUP0003256A2 (hu) | Pentozán-poliszulfát és sói alkalmazása krónikus progresszív érhegesedéssel járó betegségek kezelésére alkalmas gyógyszerkészítmények előállítására | |
HK1045456A1 (en) | Novel therapeutic use of viral inflammation modulatory protein in blocking xenograft rejection | |
DE69819922D1 (de) | 2-Amino-6-methyl-7-acetyl-tetralin und pharmazeutische Zusammensetzungen zur Vorbeugung und therapeutischen Behandlung von entzündlichen und/oder Autoimmunkrankheiten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HFG4 | Patent granted, date of granting |
Effective date: 20051003 |